|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Fauci, A. S., and G. Pantaleo. 1996. Immunopathogenic mechanisms of HIV infection. Annals of Internal Medicine 124(7):654–663. French, M. A., P. Price, and S. F. Stone. 2004. Immune restoration disease after antiretroviral therapy. AIDS 18(12):1615–1627. Hoffman, J., J. van Griensven, R. Colebunders, and M. McKellar. 2010. Role of the CD4 count in HIV management. HIV Therapy 4(1):27–39. Jevtovi, D. J., D. Salemovi, J. Ranin, I. Pei, S. Derjav, and O. Djurkovi-Djakovi. 2005. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy. HIV Medicine 6(2):140–143. Justice, A., S. J. Gange, J. P. Tate, L. P. Jacobson, K. Gebo, K. Althoff, M. Kitahata, M. Saag, M. Horberg, and R. Moore for the NA-ACCORD and VACS Project Teams. 2010 (unpublished). Report to the Institute of Medicine committee evaluating disability criteria for those with HIV infection. Klimas, N., A. O’Brien Koneru, and M. A. Fletcher. 2008. Overview of HIV. Psychosomatic Medicine 70(5):523–530. Knobel, H., A. Guelar, A. Carmona, M. Espona, A. González, J. L. López-Colomés, P. Saballs, J. L. Gimeno, and A. Díez. 2001. Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. AIDS Patient Care and STDs 15(4):193–199. Manabe, Y., J. Campbell, E. Sydnor, and R. Moore. 2007. Immune reconstitution inflammatory syndrome: Risk factors and treatment implications. Journal of Acquired Immune Deficiency Syndromes 46(4):456–462. Mellors, J. W., C. R. Rinaldo Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272(5265):1167–1170. Mellors, J. W., J. B. Margolick, J. P. Phair, C. R. Rinaldo, R. Detels, L. P. Jacobson, and A. Munoz. 2007. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. Journal of the American Medical Association 297(21):2349–2350. Meyers, D., T. Wolff, K. Gregory, L. Marion, V. Moyer, H. Nelson, D. Petitti, and G. F. Sawaya. 2008. USPSTF recommendations for STI screening. (Prepared for the U.S. Preventive Services Task Force.) American Family Physician 77:819–824, http://www.ahrq.gov/clinic/uspstf08/methods/stinfections.htm (accessed June 18, 2010). Mocroft, A., and the EuroSIDA Study Group. 2010 (unpublished). The incidence and probability of death in HIV-infected persons pre- and post-cART. University College London. Robbins, G. K., J. G. Spritzler, E. S. Chan, D. M. Asmuth, R. T. Gandhi, B. A. Rodriguez, G. Skowron, P. R. Skolnik, R. W. Shafer, and R. B. Pollard. 2009. Incomplete reconstitution of T-cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group Protocol 384. Clinical Infectious Diseases 48(3):350–361. Shelburne, S. A., M. Montes, and R. J. Hamill. 2006. Immune reconstitution inflammatory syndrome: More answers, more questions. Journal of Antimicrobial Chemotherapy 57(2):167–170. Yarchoan, R., D. J. Venzon, J. M. Pluda, J. Lietzau, K. M. Wyvill, A. A. Tsiatis, S. M. Steinberg, and S. Broder. 1991. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Annals of Internal Medicine 115(3):184–189.
|
|
|||||||||||||||
